Patents by Inventor Michael Aarons

Michael Aarons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES
    Publication number: 20170369506
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: August 16, 2017
    Publication date: December 28, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • Heteroaromatic compounds and their use as dopamine D1 ligands
    Patent number: 9850232
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: December 26, 2017
    Assignee: PFIZER INC.
    Inventors: David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Michael Eric Green, Chakrapani Subramanyam
  • WIRELESS DEVICE ENABLED LOCKING SYSTEM
    Publication number: 20170365113
    Abstract: An encrypted security system and associated methods for controlling physical access. The system includes a security server configured to receive a request for authentication from a mobile device, the request comprising information identifying the mobile device and a physical access control device. The security server forwards an encryption message comprising a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism.
    Type: Application
    Filed: June 23, 2017
    Publication date: December 21, 2017
    Inventors: Gary L. Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
    Patent number: 9845301
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, traumatic brain injury, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: December 19, 2017
    Assignee: PFIZER INC.
    Inventors: Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert, Christopher John Helal, Douglas Scott Johnson, Justin Ian Montgomery, Steven Victor O'Neil, Bruce Nelsen Rogers, Patrick Robert Verhoest, Damien Webb
  • Optical connections system and methods for positioning an optical fiber within an alignment device
    Patent number: 9829643
    Abstract: A method for positioning an optical fiber having an end portion within an alignment groove of an alignment device includes orienting the optical fiber in the alignment groove of the alignment device; causing the optical fiber to elastically flex; using an interference point to assist in forming a curved profile of the flexed fiber, and using inherent elasticity of the flexed optical fiber to assist in retaining the end portion of the optical fiber in contact with the alignment groove. A connection system includes a connector, alignment device, and adapter, with an interference point on at least one of the connector, alignment device, or adapter.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: November 28, 2017
    Assignee: CommScope Technologies LLC
    Inventors: Michael Aaron Kadar-Kallen, Robert Charles Flaig, Dwight A. Bretz, Randall Bobby Paul, Michael Lawerence Gurreri
  • Heteroaromatic compounds and their use as dopamine D1 ligands
    Patent number: 9822097
    Abstract: The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), age-related cognitive decline, dementia, and Parkinson's disease.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: November 21, 2017
    Assignee: PFIZER INC.
    Inventors: Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray, Michael Eric Green, Jaclyn Louise Henderson, Chewah Lee, Scot Richard Mente, Steven Victor O'Neil, Bruce Nelsen Rogers, Lei Zhang
  • BIOACTIVE POLYMERIC LIQUID FORMULATIONS OF ABSORBABLE, SEGMENTED APLIPHATIC POLYURETHANE COMPOSITIONS
    Publication number: 20170313808
    Abstract: Bioactive liquid formulations are formed of combinations of absorbable, segmented aliphatic polyurethane compositions and liquid polyether for use as vehicles for the controlled release of at least one active agent for the conventional and unconventional treatment of different forms of cancer and the management of at least one type of bacterial, fungal, and viral infection.
    Type: Application
    Filed: July 17, 2017
    Publication date: November 2, 2017
    Inventors: Shalaby W. Shalaby, Joel T. Corbett, Michael Aaron Vaughn, David Ingram
  • VEHICLE ACCESS CONTROL SYSTEM AND METHOD
    Publication number: 20170313280
    Abstract: A vehicle access and control system includes an activation system, a vehicle control system, a communication system provided in the vehicle, a computer system mounted in the vehicle, and a vehicle access control system including a processor, a non-volatile memory, and a set of instructions stored on the non-volatile memory. The set of instructions, when executed by the processor, causing the processor to receive a user specific identification input, access a user profile associated with the user specific identification input, determine, from the user profile, system permissions associated with the user specific identification input, and manage access to one or more of the activation system, vehicle control system, communication system, and the computer system based on the system permissions.
    Type: Application
    Filed: April 27, 2017
    Publication date: November 2, 2017
    Inventors: Michael Aaron Connor, Grace Valeria Tilton
  • N-[2-(2-AMINO-6,6-DISUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL)-1,3-THIAZOL-4-YL] AMIDES
    Publication number: 20170305931
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • 2-Amino-6-Methyl-4,4a,5,6-Tetrahydropyrano[3,4-d][1,3]Thiazin-8a(8H)-yl-1,3-Thiazol-4-yl Amides
    Publication number: 20170304312
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 26, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • System and method for access control via mobile device
    Patent number: 9781599
    Abstract: A system is described for controlling an actuating unit that restricts physical access such as a motorized garage door actuator unit. The system comprises a mobile wireless communication device, an electro-mechanical access control security device, and a receiving unit controlling the electro-mechanical access control security device, the receiving unit paired with the mobile wireless communication device for receiving user input for activating the electro-mechanical access control security device via a peer-to-peer communication directly with the mobile wireless communication device, and a pre-authorization of communication of the receiving unit with the mobile wireless communication device, the mobile wireless communication device receiving the pre-authorization from a central security server.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: October 3, 2017
    Assignee: Delphian Systems, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]OXAZIN-8a(8H)-yl)-thiazol-4-yl) amides
    Patent number: 9771379
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: September 26, 2017
    Assignee: PFIZER INC.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • Ranking search results
    Patent number: 9767159
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for providing ranked search results responsive to a query. In one aspect, a method includes receiving, from a user device, a query specifying an entity, determining two or more resources each of which provide media content related to the entity, for each of the resources, determining an effectiveness measure that is a measure of the effectiveness of the resource to present, to a user of the user device, the media content related to the entity, ranking the resources using, at least in part, the respective effectiveness measure, and providing, to the user device, a presentation of search results for the ranked resources.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: September 19, 2017
    Assignee: Google Inc.
    Inventors: Steve Chen, Sara Su, Michael Aaron Safyan, Jason B. Douglas, Samuel Shoji Fukujima Goto
  • N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides
    Patent number: 9751895
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: September 5, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • EXECUTABLE CODE IN A MEDIA FILE
    Publication number: 20170249057
    Abstract: Examples disclosed herein provide executable code within a media file. One example method includes identifying, via a processor, a media file that is to include executable code; and inserting, via the processor, the executable code into a track of the media file, the executable code to be executed upon playback of media within the media file and, when executed, the executable code is to cause control of an environment of a host device playing back the media.
    Type: Application
    Filed: September 30, 2014
    Publication date: August 31, 2017
    Applicant: HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP
    Inventors: Michael AARON, Eli REVACH, Amos NESHER
  • 2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
    Patent number: 9744173
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: August 29, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Heterocyclic compounds and their use as dopamine D1 ligands
    Patent number: 9745317
    Abstract: The present invention provides, in part, compounds of Formula (I): and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: August 29, 2017
    Assignee: Pfizer Inc.
    Inventors: David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, Michael Eric Green, Steven Victor O'Neil, Bruce Nelsen Rogers
  • RETAIN DATA ABOVE THRESHOLD
    Publication number: 20170242916
    Abstract: According to an example, different types of data stored at a database may be identified. The identified data may be scored, where different types of data are scored according to different schemes. The scored data that is above a threshold may be selectively retained. The different schemes may relate to measuring a relevancy of the identified data for predicting behavior of a system.
    Type: Application
    Filed: September 29, 2014
    Publication date: August 24, 2017
    Applicant: HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP
    Inventors: Eli REVACH, Michael AARON, Amos NESHER, Shahar TAL
  • COMMUNICATION LINK ACCESSIBILITY AWARE NAVIGATION
    Publication number: 20170229023
    Abstract: A method of communication link accessibility aware navigation is provided that includes querying a communication link accessibility map based on a location of interest provided by a path planner for a communication node. A communication link accessibility indicator is received representing a communication link characteristic associated with the location of interest in response to querying the communication link accessibility map. A communication link accessibility weight is determined based on a mission priority of maintaining a communication link of the communication node. The communication link accessibility weight is applied to the communication link accessibility indicator.
    Type: Application
    Filed: October 27, 2015
    Publication date: August 10, 2017
    Applicant: SIKORSKY AIRCRAFT CORPORATION
    Inventors: Michael Aaron Connor, George Nicholas Loussides, Harshad S. Sane
  • ISSUE RESOLUTION PLATFORM
    Publication number: 20170221071
    Abstract: An issue resolution platform is implemented on a computer system that communicates with user devices over a network.
    Type: Application
    Filed: January 31, 2016
    Publication date: August 3, 2017
    Inventor: Michael Aaron Eton York